HEIDELBERG, Deutschland–(BUSINESS WIRE)–Novaliq GmbH, ein spezialisiertes pharmazeutisches Unternehmen mit einer disruptiven Drug-Delivery-Plattform, die schwer lösliche Arzneimittel in wirksame Therapeutika für die Augenheilkunde verwandelt, meldete heute, dass vier wissenschaftliche Poster im Rahmen der Jahrestagung 2018 der Association for Research in Vision and Ophthalmology (ARVO) vom 29. April bis 3. Mai in Honolulu (Hawaii) präsentiert werden. Die Vielfalt der zu präsentierenden Daten
Author: Business Wire
Novaliq présentera une recherche scientifique et clinique lors de la conférence 2018 de l’Association pour la recherche en vision et en ophtalmologie à Honolulu, Hawaï
HEIDELBERG, Allemagne–(BUSINESS WIRE)–Novaliq GmbH, société pharmaceutique spécialisée possèdant une plateforme d’administration de médicaments d’avant-garde, transformant des médicaments peu solubles en produits ophtalmologiques efficaces, a annoncé aujourd’hui que quatre affiches scientifiques seront présentées lors de la conférence 2018 de l’Association pour la recherche en vision et ophtalmologie (ARVO) d’Honolulu à Hawaï (29 avril-3 mai). La variété des données présentées reflète l’engag
Riassunto: Novaliq presenterà una ricerca clinico-scientifica al congresso 2018 della Association for Research in Vision and Ophthalmology a Honolulu, Hawaii
HEIDELBERG, Germania–(BUSINESS WIRE)–Novaliq GmbH, produttore di specialità farmaceutiche con una piattaforma di distribuzione di farmaci totalmente innovativa in grado di trasformare medicinali scarsamente solubili in terapie oftalmiche efficaci, ha annunciato oggi che presenterà quattro poster scientifici al congresso 2018 della Association for Research in Vision and Ophthalmology (ARVO) a Honolulu, Hawaii, (29 aprile-3 maggio). La varietà dei dati che saranno presentati riflette la dedizio
SeniorWell Hires New Chief Operating Officer
CHICAGO–(BUSINESS WIRE)–SeniorWell, a mobile healthcare company, today announced the hiring of Sherri Peavy, MBA, BSN, RN as Chief Operating Officer.
Novaliq to Present Scientific and Clinical Research During the 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu, HI
HEIDELBERG, Germany–(BUSINESS WIRE)–#ARVO–Novaliq GmbH will present four scientific posters at the 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu April 29-May 3.
Global Cataract Surgery Market Forecasts 2018-2023 – A $3 Billion Market Opportunity – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Market – Forecasts from 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The global cataract surgery market is predicted to witness a compound annual growth rate of 5.02% during th…
Breakthrough Augmented Reality Designed for the Mass Market (Consumer and Enterprise)
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Breakthrough Augmented Reality Designed for the Mass Market (Consumer and Enterprise)
CheckedUp Announces Content Licensing Initiative with The American Academy of Ophthalmology to Strengthen its Patient Education Offerings
NEW YORK–(BUSINESS WIRE)–CheckedUp features content from the AAO, leading educational partner, to educate and empower patients in their doctors’ offices.
Guardion Health Sciences to Present at Planet Microcap Showcase 2018 Las Vegas
SAN DIEGO,Calif.–(BUSINESS WIRE)–Guardion Health Sciences to Present at Planet Microcap Showcase 2018 Las Vegas
Graybug Vision Announces Presentations on Novel Treatments for Wet AMD and Glaucoma at ARVO 2018 Annual Meeting
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Graybug Vision Announces Presentations on Novel Treatments for Wet AMD and Glaucoma at ARVO 2018 Annual Meeting
MeiraGTx Announces AAV-RPGR Granted Fast Track Designation by U.S. FDA for Treatment of X-Linked Retinitis Pigmentosa Due to RPGR Deficiency
LONDON & NEW YORK–(BUSINESS WIRE)–MeiraGTx Limited, a vertically integrated, clinical stage gene therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for AAV-RPGR for the treatment of X-linked retinitis pigmentosa (XLRP) due to defects in the retinitis pigmentosa GTPase regulator (RPGR) gene. “XLRP is a devastating condition that causes rapid progression to blindness and currently has no approved treatment options. This Fast Trac
Uveitis Pipeline Highlights – 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. Uveitis Pipeline Highlights – 2018, provides the most up-to-date information on key pipeline products in the global Uveitis ma…
Glaukos Corporation to Release First Quarter 2018 Financial Results after Market Close on May 9
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release first quarter 2018 financial results after the market close on Wednesday, May 9, 2018. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PDT (4:30 p.m. EDT) on May 9,
Global Dry Eye Epidemiology and Patient Flow Analysis 2017-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Dry Eye epidemiology, Dry Eye diagnosed patients, and Dry Eye tr…
Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Diabetic Macular Edema epidemiology, Diabetic Mac…
Age-Related Macular Degeneration Pipeline Highlights Report 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Age-Related Macular Degeneration Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products in the global Age-Relat…
Zenni Optical Marks 15th Anniversary by Selling 20 Millionth Pair of Glasses
NOVATO, Calif.–(BUSINESS WIRE)–#15yearsofZenni–Zenni Optical, the online optical industry leader, celebrates 15 years of innovation this month with a milestone of 20 million pairs of glasses sold.
Additional Clinical Studies Supporting the Benefits of OMIDRIA® Presented at the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER) announced that the results of four real-world clinical studies evaluating the benefits of OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1% / 0.3% were presented at the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting held in Washington, D.C., April 13-17, 2018. The studies examined the use of OMIDRIA in both routine and complex cataract surgery cases perf
$13 Billion Contact Lenses Market – Global Outlook and Forecast 2018-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market – Global Outlook and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering. The global contact lenses market is anticipated to generate revenues of more than $13 billion by 20…
2018 Macular Edema Pipeline Highlights – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Macular Edema Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. Macular Edema Pipeline Highlights – 2018 provides the most up-to-date information on key pipeline products in the global…